SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000920465-14-000049
Filing Date
2014-06-27
Accepted
2014-06-27 16:42:26
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 s-3june2014doc.htm S-3 179771
2 EXHIBIT a51optionofgibsondunns-3.htm EX-5.1 27321
3 EXHIBIT a231consentofsquars-3.htm EX-23.1 3268
4 gdlogo.jpg GRAPHIC 4607
5 logolajollacolorjun13.jpg GRAPHIC 164429
  Complete submission text file 0000920465-14-000049.txt   444510
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-197092 | Film No.: 14946409
SIC: 2836 Biological Products, (No Diagnostic Substances)